Logo image of VIVE

VIVEVE MEDICAL INC (VIVE) Stock Analyst Earnings Estimates

NASDAQ:VIVE - Nasdaq - US92852W5013 - Common Stock - Currency: USD

0.2201  -0.04 (-15.35%)

After market: 0.2151 0 (-2.27%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024
Revenue
YoY % growth
VIVE revenue by date.VIVE revenue by date.
6.57M
-64.52%
5.48M
-16.59%
6.426M
17.26%
7.028M
9.37%
11.363M
61.68%
22.328M
96.50%
EBITDA
YoY % growth
VIVE ebitda by date.VIVE ebitda by date.
-28.75M
34.93%
-17.2M
40.17%
-20.43M
-18.78%
N/AN/AN/A
EBIT
YoY % growth
VIVE ebit by date.VIVE ebit by date.
-29.93M
33.44%
-18.5M
38.19%
-21.553M
-16.50%
-20.93M
2.89%
-20.533M
1.90%
-14.321M
30.25%
Operating Margin
VIVE operating margin by date.VIVE operating margin by date.
-455.56%-337.59%-335.40%-297.81%-180.70%-64.14%
EPS
YoY % growth
VIVE eps by date.VIVE eps by date.
-608.87
62.65%
-17.05
97.20%
-2.81
83.52%
-2.60
7.44%
-1.63
37.25%
-0.99
39.38%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth
-0.63
12.17%
-0.48
28.45%
-0.43
36.06%
-0.38
36.03%
-0.35
45.16%
-0.28
42.55%
-0.26
40.48%
-0.22
40.54%
-0.23
32.35%
Revenue
Q2Q % growth
1.805M
5.80%
2.173M
32.42%
2.56M
42.62%
3.009M
78.68%
3.621M
100.61%
4.457M
105.11%
5.131M
100.43%
5.865M
94.92%
6.875M
89.86%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-5.467M
8.68%
-5.753M
-5.11%
-5.294M
-5.45%
-4.702M
-0.86%
-4.794M
12.31%
-4.192M
27.13%
-3.815M
27.94%
-3.101M
34.06%
-3.213M
32.98%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth
-0.59
11.94%
-0.670.0812.36%
Q2 2022
Q2Q % growth
-0.67
-8.06%
-0.680.011.96%
Q1 2022
Q2Q % growth
-0.67
16.25%
-0.690.022.69%
Q4 2021
Q2Q % growth
-0.72
61.08%
-0.61-0.11-18.64%
Q3 2021
Q2Q % growth
-0.67
74.23%
-0.63-0.04-6.81%
Q2 2021
Q2Q % growth
-0.62
85.91%
-0.660.046.49%
Q1 2021
Q2Q % growth
-0.80
90.24%
-0.52-0.28-53.79%
Q4 2020
Q2Q % growth
-1.85
95.77%
-2.650.8030.11%
Q3 2020
Q2Q % growth
-2.60
98.08%
-5.412.8151.91%
Q2 2020
Q2Q % growth
-4.40
97.90%
-6.021.6226.89%
Q1 2020
Q2Q % growth
-8.20
96.27%
-128.52120.3293.62%
Q4 2019
Q2Q % growth
-43.77 -12.65-31.12-246.06%
Q3 2019
Q2Q % growth
-135.10 -163.2028.1017.22%
Q2 2019
Q2Q % growth
-210.00 -181.90-28.10-15.45%
Q1 2019
Q2Q % growth
-220.00 -269.7349.7318.44%
VIVE Yearly EPS VS EstimatesVIVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth
1.684M
4.21%
1.739M-55K-3.16%
Q2 2022
Q2Q % growth
1.795M
8.52%
1.795M0.00%
Q1 2022
Q2Q % growth
1.641M
13.17%
1.77M-129K-7.29%
Q4 2021
Q2Q % growth
1.706M
-12.51%
1.739M-33K-1.90%
Q3 2021
Q2Q % growth
1.616M
6.32%
1.724M-108K-6.26%
Q2 2021
Q2Q % growth
1.654M
136.29%
1.556M98K6.30%
Q1 2021
Q2Q % growth
1.45M
11.54%
1.357M93K6.85%
Q4 2020
Q2Q % growth
1.95M
34.48%
1.892M58K3.07%
Q3 2020
Q2Q % growth
1.52M
44.76%
1.02M500K49.02%
Q2 2020
Q2Q % growth
700K
-33.33%
540.6K159.4K29.49%
Q1 2020
Q2Q % growth
1.3M
-56.81%
1.132M168K14.84%
Q4 2019
Q2Q % growth
1.45M 1.142M308K26.97%
Q3 2019
Q2Q % growth
1.05M 1.724M-674K-39.10%
Q2 2019
Q2Q % growth
1.05M 3.766M-2.716M-72.12%
Q1 2019
Q2Q % growth
3.01M 3.091M-81K-2.62%
VIVE Yearly Revenue VS EstimatesVIVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 5.34% 0% 3.77%
Revenue0% -3.83% 0% -1.78%